Print
IAVI P001
Trial Details:
Phase:
I
Status:
Completed
Organizer developer:
International AIDS Vaccine Initiative (IAVI), Aaron Diamond AIDS Research Center
Start Date:
April 02, 2009
Product:
ADVAX,TBC-M4
Antigen:
DNA Nef, Gag, Env, Tat, Pol C; Pox env, gag, tat-rev, and nef-RT C
Prime 1:
ADVAX
Prime Class:
DNA
Boost 1:
TBC-M4
Boost 1 class:
Viral Vector - Pox
Boost 2:
Boost 2 Class:
Boost 3:
Boost 3 Class:
Adjuvant:
Country:
India
Volunteers:
32
ClinicalTrials.gov Identifier:
Link: